SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing intense investor focus as the community anticipates the launch of three BlueBird satellites via SpaceX, an event seen as a critical operational catalyst for the company's direct-to-device broadband network. Discussions are dominated by debates over the company's long-term competitive position against Starlink, with many investors viewing this launch as a pivotal step toward achieving consistent service and potential revenue growth.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is currently trending as investors react to the unveiling of new AR-focused smart glasses, with intense community debate over the product's high price point and the company's long-term pivot toward hardware. While some participants argue that the technology and extensive patent portfolio provide significant future value, many shareholders are expressing frustration with management and calling for a shift in leadership or a change in corporate strategy.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is currently facing significant downward pressure and extreme volatility as investors express frustration over its 52-week lows and decoupling from positive broader market sentiment. The community remains deeply divided, with many traders lamenting the stock's persistent sell-offs while others emphasize long-term conviction in XPeng's potential for physical AI and robotics to drive a future re-rating.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The DJIA is currently at the center of intense community debate regarding the impact of ongoing Middle East geopolitical tensions on inflation and potential market volatility. Investors are actively weighing bullish trend forecasts against concerns over economic data and the sustainability of current market levels.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is gaining momentum as investors react to its rapidly expanding global autonomous fleet, strategic partnerships with major OEMs like Geely and GAC, and a $100 million share repurchase program. The community is actively discussing the company's valuation gap compared to Western competitors and closely monitoring its upcoming Q1 earnings report for signs of sustained revenue growth.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is seeing massive investor activity driven by a robust trading update that maintained strong guidance despite geopolitical disruptions and multiple contract wins in its SMR and defense divisions. The community is actively discussing the company's successful turnaround into a high-margin industrial power and debating the impact of long-term sector tailwinds against temporary macroeconomic pressures.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnite is gaining traction as community members react positively to strong CTV growth figures and the company's commitment to aggressive share repurchases despite broader market volatility. Investors are actively discussing the potential upside from upcoming legal catalysts and the company's evolving role as a critical infrastructure layer in the programmatic advertising ecosystem.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors debate the regulatory outlook for its Axpaxli wet AMD treatment, specifically whether the SOL-1 data is sufficient for FDA approval or if additional trials are required. The community is actively discussing potential M&A activity, institutional ownership levels, and the upcoming Investor Day event as key factors that may drive volatility.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a momentum leader in the semiconductor sector, with community discourse driven by aggressive price target upgrades from analysts and strong demand for AI-linked memory components. Traders are actively debating the stock's parabolic trajectory and potential for further gains, while closely monitoring macroeconomic catalysts like upcoming interest rate decisions and geopolitical shifts in the energy sector.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is driving intense market activity following a high-profile IPO and a successful Falcon 9 launch, fueling community debate over its massive valuation relative to current revenue. While bullish investors are focused on its potential as a dominant AI and orbital infrastructure player, bearish participants are sounding alarms regarding a low public float and impending share lockup expirations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunovant Stock Gains 12.4% in a Month: What's Driving It?

IMVT shares climb as IMVT-1402 posts encouraging data, advances across autoimmune diseases and benefits from a cash runway extending through launch.

H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data

H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data...

The Biotech Supercycle Is Here: Retatrutide, VERVE-102, NEO100, and More Set to Transform Medicine

Biotechnology investors are entering one of the most catalyst-heavy clinical cycles in years as a wave of Phase 2 and Phase 3 programs begins reshaping expectations across obesity, oncology, gene editing, autoimmune disease, and neurological disorders. $LLY, $NVO, $NTHI, $BAC, $STT, $BCS, $IMVT, $SRPT, $MRNA, $CRSP

These Analysts Increase Their Forecasts On Immunovant After Q4 Results

Immunovant (NASDAQ:IMVT) reported a Q4 loss of 73 cents/share, missing estimates of 60 cents. R&D expenses rose to $142.3 million. Analysts adjust price targets.read more...

IMVT's Q4 Loss Wider Than Expected, Stock Up 35% on Strong Study Data

Immunovant stock jumps 35% as strong early IMVT-1402 data in rheumatoid arthritis boosts confidence despite a wider Q4 loss.

IMVT Rockets 35% Despite Wider Loss As Arthritis Drug Shines In Study

Equity

Immunovant posted encouraging Phase 2 data for its rheumatoid arthritis therapy, even as fourth-quarter net loss came in wider than expected.

Can a New Arthritis Drug Make Immunovant the Next Biotech Star?

Can a New Arthritis Drug Make Immunovant the Next Biotech Star...

Clinical Catalysts Driving Momentum, Plus an Oldie and a Newie

Clinical catalysts are driving the market, this morning, plus a mover we’ve been covering for weeks and a new runner. $NTHI, $IMVT, $IBRX, $AMPG, $POET, $MWC

Immunovant, Inc. $IMVT Shares Sold by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA lowered its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 43.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 380,842 shares of the company's stoc...

Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Hold" from Analysts

Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) has been assigned a consensus recommendation of "Hold" from the eleven research firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommenda...

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It develops a novel, fully human monoclonal antibody, IMVT-1401, which selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded on July 6, 2018 and is headquartered in Durham, NC.

IMVTImmunovant Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMVT News